Heterogeneity of HBV-Specific CD8(+) T-Cell Failure: Implications for Immunotherapy
November 4, 2019 2:47 pmHeim, K., Neumann-Haefelin, R. Thimme, and M. Hofmann. 2019. Heterogeneity of HBV-Specific CD8(+) T-Cell Failure: Implications for Immunotherapy. Front Immunol 10: 2240.
Categorised in:
This post was written by Heike Ufheil